Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Geofrey Mukwada says funding from the US Embassy and Consulates in South Africa will reinforce the ARU mandate.

The University of the Free State (UFS) will further strengthen its ties with the Appalachian State University in the next two academic years through a mountain-to-mountain research project funded by the US Embassy and Consulates in South Africa.

The R8 million project between the UFS and the US institution will cover the two master’s degree programmes in underdeveloped niche areas, meteorological weather stations, leadership capacity building for black women in academia, and doctoral research projects. Qwaqwa Campus departments that will be involved are Physics, Geography, Community Development, and the ARU.

Talking about this collaboration, the project leader, Prof Geofrey Mukwada, said it would bring together researchers from both the UFS and Appalachian State University and enable them to work together to develop what is currently an underdeveloped research niche, i.e. mountain studies. 

“This project will reinforce the mandate of the Afromontane Research Unit (ARU). It will provide the basis for a long-term development agenda through training and infrastructure development. For instance, the project will fund the implementation of two master’s degree programmes – the MSc in Mountain Environments and the MA in Community Development – which are long-term projects,” he said. 

“It will also support innovation in climate change research. Through this project, it will be possible to receive climate data from weather stations that are situated in distant, isolated, and generally inaccessible locations without travelling to those locations. We will be able to understand how the climate of the region is changing and assist in developing adaptation measures and decisions that are applicable to agriculture, water, tourism, environment, and other sectors. This will enhance the capacity of the ARU to contribute to the development of research in mountain environments,” he added. 

There will be a virtual launch of the project on Tuesday 10 November 2020 at 15:00 (CAT).

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept